Physician profile
Vishal Gupta
NPI 1255449179
$24,696.58
in general payments reported to CMS, 2019-2025
48 companies · $11K in 2025
The $11K reported for 2025 was more than what 93% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $857 · 2020: $570 · 2021: $916 · 2022: $763 · 2023: $5,944 · 2024: $4,151 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Food and Beverage: $4,695 · Education: $95.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,800.00 |
| Food and Beverage | $4,695.13 |
| Education | $95.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $17,655.77 | 2021-2025 | Interstim |
| Abbvie INC. | $2,076.42 | 2019-2025 | |
| Phathom Pharmaceuticals, INC. | $658.48 | 2024 | Voquezna |
| Janssen Biotech, INC. | $515.05 | 2019-2025 | Stelara, Tremfya, Simponi Aria |
| Takeda Pharmaceuticals U.S.A., INC. | $406.90 | 2019-2025 | Entyvio, Eohilia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $280.12 | 2019-2025 | Plenvu, Xifaxan |
| Pfizer INC. | $266.38 | 2019-2025 | |
| Ucb, INC. | $228.67 | 2019-2022 | |
| Gilead Sciences, INC. | $217.71 | 2019-2025 | |
| Lilly USA, LLC | $191.28 | 2024-2025 | Omvoh |
| Intercept Pharmaceuticals, INC. | $176.30 | 2019-2025 | |
| Olympus America INC. | $162.71 | 2024 | Endoclot Phs, Olympus, Visiglide |
| Genzyme Corporation | $123.61 | 2022-2024 | |
| Nestle Healthcare Nutrition INC. | $121.77 | 2021-2023 | |
| Braintree Laboratories, INC. | $116.74 | 2019-2024 | Suflave, Sutab |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $94.09 | 2024-2025 | Zenpep |
| Qol Medical, LLC | $91.58 | 2019-2022 | |
| Alnylam Pharmaceuticals INC. | $81.00 | 2021-2024 | Givlaari |
| Anx Robotica Corp | $79.39 | 2025 | |
| Ironwood Pharmaceuticals, INC | $67.56 | 2019-2022 | |
| Enterra Medical, INC. | $64.74 | 2023-2025 | |
| Axonics, INC. | $62.37 | 2020-2024 | Axonics |
| Ferring Pharmaceuticals INC. | $61.21 | 2020-2023 | Rebyota |
| Celltrion USA INC. | $61.20 | 2024 | Zymfentra |
| Asahi Intecc USA, INC. | $60.00 | 2019 | |
| Ardelyx, INC. | $55.08 | 2023-2024 | Ibsrela |
| Allergan, INC. | $54.81 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $54.64 | 2025 | Iqirvo |
| Redhill Biopharma INC. | $54.09 | 2020-2021 | |
| Madrigal Pharmaceuticals | $51.40 | 2024-2025 | Rezdiffra, Resmetirom |
| Echosens North America, INC. | $50.00 | 2019 | |
| Ovik Health, LLC | $48.74 | 2024 | Coflex Tlc |
| Medtronic USA, INC. | $46.77 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $46.61 | 2023 | Dupixent |
| Endo Pharmaceuticals INC. | $43.83 | 2019-2020 | |
| Organon LLC | $42.07 | 2023 | Hadlima |
| Vivus LLC | $41.74 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $38.16 | 2024-2025 | Zeposia, Camzyos |
| Celgene Corporation | $37.58 | 2023-2024 | Zeposia |
| Mallinckrodt Hospital Products INC. | $24.65 | 2025 | Terlivaz |
| Daiichi Sankyo INC. | $24.13 | 2021 | |
| Genentech USA, INC. | $17.76 | 2023 | Tecentriq |
| Springworks Therapeutics, INC. | $17.43 | 2025 | |
| Creo Medical INC. | $14.80 | 2024 | Speedboat Ultraslim (Sb1l) |
| Ethicon US, LLC | $11.24 | 2020 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vishal Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.